Literature DB >> 2650819

Hypermetabolism-organ failure syndrome: a metabolic response to injury.

F B Cerra1.   

Abstract

The hypermetabolism-organ failure syndrome, a common disease entity, continues to account for most of the ICU deaths in surgical patients. This article reviews the phases of the response to injury process that culminates in organ failure and describes the patterns it may take. Current therapy for hypermetabolism-organ failure syndrome is also reviewed.

Entities:  

Mesh:

Year:  1989        PMID: 2650819

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

1.  Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle.

Authors:  T C Vary; S Hazen
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

2.  Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic shock.

Authors:  A S Santibanez-Gallerani; A E Barber; S J Williams; S Davis; Y Zhao; G T Shires
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

3.  Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes.

Authors:  Eleonora Feketeova; Zhifeng Li; Biju Joseph; Roshan Shah; Zoltan Spolarics; Luis Ulloa
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

4.  Glucose Activates Vagal Control of Hyperglycemia and Inflammation in Fasted Mice.

Authors:  Biju Joseph; Guilherme Shimojo; Zhifeng Li; Maria Del Rocio Thompson-Bonilla; Roshan Shah; Alexandre Kanashiro; Helio C Salgado; Luis Ulloa
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.